ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024
October 17, 2024 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to...
ClearPoint Neuro Announces Early Repayment of $10 Million Note
August 26, 2024 16:05 ET
|
ClearPoint Neuro, Inc.
ClearPoint Neuro clears all debt from balance sheet after early repayment of principal & interest on $10 million convertible note held by PTC Therapeutics
ClearPoint Neuro Reports Second Quarter 2024 Results
August 07, 2024 16:05 ET
|
ClearPoint Neuro, Inc.
ClearPoint Neuro reported Q2 2024 revenue of $7.9M, up 32% YoY, and raised full-year guidance to $30-33M #CLPT
ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024
July 17, 2024 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to...
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
June 20, 2024 08:45 ET
|
ClearPoint Neuro, Inc.
ClearPoint® Navigation System to be used for all enrolled patients in Aspen's ASPIRO Parkinson's cell therapy clinical trial
ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
June 01, 2024 09:00 ET
|
ClearPoint Neuro, Inc.
Newly Launched ClearPoint Neuro technology - SmartFrame OR and Prism Laser will be on display at ASSFN in Nashville from June 1 - 4
ClearPoint Neuro Reports First Quarter 2024 Results
May 07, 2024 16:05 ET
|
ClearPoint Neuro, Inc.
Q1-2024 Revenue Growth +41%, a Company Record
ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore
May 02, 2024 16:05 ET
|
ClearPoint Neuro, Inc.
Novel drug delivery research to be presented by ClearPoint Neuro Biologics team at ASGCT 2024 Annual Meeting in Baltimore
ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory
April 29, 2024 08:00 ET
|
ClearPoint Neuro, Inc.
FDA Clearance of Prism Bone Anchor Accessory will expand use of the ClearPoint Prism® Neuro Laser Therapy to Operating Room
ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System
April 24, 2024 16:05 ET
|
ClearPoint Neuro, Inc.
First 10 operating room procedures with SmartFrame OR successfully completed. Company expects positive impact to revenue in 2024 due to OR expansion.